Want to learn more?
We offer a broad range of services to identify, qualify, and prioritise potential in/out licensing candidates and evaluate the commercial potential of the assets. From rapid assessment to comprehensive due diligence engagements, we draw upon our substantial capabilities to deliver information seamlessly within and across the phases of your engagement.
Deep understanding of market characteristics & dynamics
Our vast experience in oncology and rare diseases will help you predict and overcome challenges in your target market.
In-house expertise and efficient operations
Clinical, epidemiology, access and forecasting experts work collaboratively to ensure confident decision making.
Comprehensive and robust data sources
We have access to a broad range of data and leverage the correct sources to meet your requirements.
- Appraising the landscape, competitive market and market access
- Evaluating product clinical utility and commercial value
- Identifying, validating and advising on partnering or acquisition opportunities
- Conducting commercial and scientific due diligence
- Forecasting revenues, analysing cash flows and valuing assets
- Determining optimal market access strategies
Our multidisciplinary structure mirrors that of a typical pharma business development and licensing team, and offers comprehensive resources, with subject matter experts in clinical and commercial functions, including market access.
We can support you as part of a long-term strategic process, or with tactical support at critical points in the process, which may include an independent third-party validation.
We support our engagements with accurate and reliable data from a range of sources, including CancerMPact®, CancerLandscape®, and Epi Database®. We use a holistic approach, integrating the appropriate experts and data to meet your requirements.